Results 251 to 260 of about 69,669 (298)
Some of the next articles are maybe not open access.
The Future of Mechanical Circulatory Support
Circulation: Heart Failure, 2021Article published in Circulation: Heart Failure available at https://doi.org/10.1161/CIRCHEARTFAILURE.121 ...
Christopher S. Hayward+6 more
openaire +4 more sources
Mechanical circulatory support
Best Practice & Research Clinical Anaesthesiology, 2015Heart failure (HF) is a condition in which the heart is not able to pump enough blood and oxygen required for organ systems to function. According to recent statistics from the American Heart Association (AHA), about 5.1 million people in the nation suffer from HF; one in nine deaths in 2009 included HF as a contributing cause. About half of people who
openaire +3 more sources
Advances in mechanical circulatory support
Current Opinion in Organ Transplantation, 2008Mechanical circulatory support is expanding the treatment of advanced heart failure. The number of heart transplantations performed worldwide remains fairly static, and medical therapy alone for end stage heart failure continues to have dismal results. This article presents the authors' opinion as to the current status, challenges, and future course of
Louis B. Louis, Benjamin Sun
openaire +3 more sources
Mechanical circulatory support in pediatrics
Expert Review of Medical Devices, 2016End-stage heart failure affects thousands of children yearly and mechanical circulatory support is used at many points in their care. Extracorporeal membrane oxygenation supports both the failing heart and lungs, which has led to its use as an adjunct to cardiopulmonary resuscitation as well as in post-operative cardiogenic shock.
Kyle G. Miletic+6 more
openaire +3 more sources
Update on Mechanical Circulatory Support
Anesthesiology Clinics, 2023Mechanical circulatory support (MCS) devices provide temporary or intermediate- to long-term support for acute cardiopulmonary support. In the last 20 to 30 years, tremendous growth in MCS device usage has been seen. These devices offer support for isolated respiratory failure, isolated cardiac failure, or both.
Suzanne, Bennett+3 more
openaire +2 more sources
Mechanical circulatory support in the ICCU
Acute Cardiac Care, 2009The mortality of acute heart failure (AHF) remains high despite advances in treatment. Mechanical circulatory support (MCS) can be applied in AHF, refractory to conventional measures, to improve outcomes. This article aims to describe the current and the prospective role of MCS in the treatment of AHF.
Antonis A. Pitsis, Aikaterini N. Visouli
openaire +3 more sources
Pediatric Mechanical Circulatory Support
The International Journal of Artificial Organs, 2006Over the past two decades clinicians and researchers have sought to bring mechanical circulatory support (MCS) to pediatric patients with heart failure. ECMO, IABPs, and VADs have all been used in infants and children as a bridge to myocardial recovery or as a bridge to transplant.
David L.S. Morales+2 more
openaire +3 more sources
Mechanical circulatory support in the 1990s
European Journal of Cardio-Thoracic Surgery, 1992The current experience in bridging patients to weaning (more than 965 implants) and to transplantation (more than 544 implants) has shown the feasibility of mechanical circulatory support in patients with major cardiac dysfunction, who are unresponsive to optimal medical management.
openaire +3 more sources
Mechanical Circulatory Support
2020Mechanical circulatory support is becoming more frequently utilised in the intensive care and cardiac surgical setting. From extra-corporal membrane oxygenation (ECMO) to ventricular assist devices (VADs), there are newer models, and variations in configurations to accommodate expanding indications. This thesis aims to determine the current progress of
openaire +2 more sources
Mechanical Circulatory Support
1998Acute cardiogenic shock has a mortality rate of 80–90%, that of chronic terminal heart failure is about 50%. For this reason, mechanical circulatory support systems were developed both for acute bridging of a potentially reversible cardiogenic shock and for longer term therapy in the form of a bridge-to-transplantation method.
Michael Böhm, Erland Erdmann
openaire +2 more sources